Table 1 Characteristics of LACC patients treated with NAC followed by RH
From: Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
Characteristics | Number | % |
|---|---|---|
Total patients | 38 | |
Median age (range) | 49 (25–69) | |
Performance status 0 | 38 | 100 |
FIGO stage | ||
1B2 | 12 | 31.6 |
2B | 26 | 68.4 |
Pathology | ||
Squamous | 36 | 94.7 |
Adenosquamous | 2 | 5.3 |
Primary tumor size | ||
>4 cm | 30 | 78.9 |
≦4 cm | 8 | 21.1 |
Tumor response after NAC | ||
CR | 5 | 13.2 |
PR | 24 | 63.1 |
SD | 8 | 21.1 |
PD | 1 | 2.6 |
Shirinkage rate | ||
>50 % | 25 | 65.8 |
≦50 % | 13 | 34.2 |
Lymph node metastasis | ||
negative | 23 | 60.5 |
positive pelvic | 15 | 39.5 |
positive aortic | 4 | 10.5 |
Recurrence | 10 | 26.3 |